As of 2025-07-15, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (46.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -8565.3%.
The range of the Relative Valuation is (43.15) - (45.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 18.0x | 17.6x |
| Forward P/E multiples | 17.0x - 22.0x | 19.0x |
| Fair Price | (43.15) - (45.80) | (46.56) |
| Upside | -7945.4% - -8426.5% | -8565.3% |
| Date | P/E |